So why are we waiting after that?’.. BMA response to start of latest DHSSPS discussion document Commenting on today’s start of the DHSSPS discussion document, ‘A WHOLESOME Upcoming’, the Chairman of the BMA’s NI Council, Dr Brian Patterson, said: ‘All of us will of program be responding completely to the latest document, as we’ve finished with previous others. Nevertheless, we are worried that there’s been so much discussion over the last amount of years with small positive outcomes.PEGASUS-TIMI 54 aims to measure the efficacy and security of ticagrelor , for the long-term avoidance of atherothrombotic occasions in patients, aged 50 and older, who experienced a coronary attack one to 3 years to review enrolment prior, and who’ve one extra cardiovascular risk element. ‘Current suggestions generally recommend 12 weeks of dual antiplatelet therapy pursuing an severe coronary syndrome event, atherothrombotic disease is a persistent however, progressive and perhaps fatal condition,’ Marc Ditmarsch continuing. ‘The PEGASUS trial can help us measure the potential long-term advantage of therapy with ticagrelor for the chronic condition.